Research News for November 9, 2022
advertisement
- New Startup Develops Potential Cure for Type 1 Diabetes
- A New and Improved Diabetes Drug
- Abnormal Expression of an Insulin Synthesizing Enzyme in Islets of Adult Autoantibody Positive Donors
- Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
- Molecular genetic etiology by whole exome sequence analysis in cases with familial type 1 diabetes mellitus without HLA haplotype predisposition or incomplete predisposition
- Differential Expression and Bioinformatics Analysis of Plasma-Derived Exosomal circRNA in Type 1 Diabetes Mellitus
- Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review
- Sox9 is required in regeneration of pancreatic β cells following injury
- Fulminant type 1 diabetes mellitus caused by long-term nivolumab administration followed by nivolumab plus cabozantinib combination
- Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening (Full text HTML)
- Safe and Personalized Meal Bolus Calculator for Type-1 Diabetes using Bayesian Optimization
